Acne

Over 6 weeks, most saw patients saw improvement, with daily medication linked to better quality of life and reduced skin picking.

At the correct dosage, researchers noted non-significant changes in BMI or metabolic syndrome markers among patients.

Although EBDs provided improvements over controls, they did not match the sebum reduction levels achieved by isotretinoin or hormonal therapies.

A recent study revealed that CO2 fractional laser was significantly more effective than microneedling for acne treatment with ALA-PDT.

While FDA action is awaited, dermatology clinicians can suggest BPO-free alternatives such as retinoids, salicylic acid, and more.

Patients with acne also had higher rates of abnormal zinc and vitamin D levels, especially in severe cases.

Investigators looked into pollutant-induced disruption of the skin barrier, increased transepidermal water loss, and heightened inflammatory responses.

The lotion effectively rebalanced the microbiota, reduced erythema and desquamation, and improved acne severity.

Social media misinformation related to acne vulgaris may require clinician intervention when discussing treatment with patients.

A recent study found that pharmacy professionals had an increased level of capability, opportunity, and motivation after accessing the resource.

Adhering to a Mediterranean diet and incorporating omega-3 supplements led to noticeable improvements in acne severity, reducing both inflammatory and non-inflammatory lesions in patients.

Andrea Zaenglein, MD, discussed the role of patient counseling and addressing "hormone phobia" in young patients treated with hormonal therapies for acne in her SPD 2024 session.

Some patients may be looking for alternatives to BPO, questioning its safety.

With the latest advancements in dermatology, there is a great range of treatments available to address the various types of acne scarring.

Researchers found that the hemp derivative addressed multiple facets of acne pathophysiology and improved acne scarring overall.

A retrospective review found that sarecycline, a narrow-spectrum tetracycline, may be beneficial for patients with POD.

Patients with acne scarring who received concurrent therapy with isotretinoin and fractional radiofrequency achieved significant reductions in acne scar volume.

Hilary Baldwin, MD, presents a case study of a 17-year-old high school student with moderate acne vulgaris on her face and back, which caused significant emotional distress and lowered self-esteem, and discusses the patient's treatment journey and the resolution achieved.

Hilary Baldwin, MD, a dermatologist, presents a case study of a 12-year-old overweight male patient with a two-year history of moderate facial acne, discussing her diagnostic process and recommended treatment plan.

Although acne is common for most people to experience in their lifetime, it is important to individualize treatment and provide appropriate care when working with a diverse patient base.

The organization is highlighting stories and resources during Acne Awareness Month through the power of social media.

Supplementation with RGLE led to clinically significant improvements in patients with acne vulgaris, according to a study.

A new acne-specific HRQoL questionnaire developed in Europe could help to create more comprehensive, individualized treatment plans.

Acinonyx Bio's topical cream, ACX, targets Propionibacterium acnes.

Authors of a recent review concluded that combining various therapies holds promise in the treatment of acne scarring.

The awarded grant will span a total of 3 years.

Aaron Farberg, MD, discusses the low-dose, affordable Accutane treatment and Clear Health’s mission to improve patient access to affordable acne therapies.

From our April cover feature: Take an in-depth look at the basis of Valisure's benzene testing methods and practical recommendations for clinicians from Christopher Bunick, MD, PhD.

Mona Gohara, MD, explained the importance of the products' impact on the skin barrier.

Over 50% of women in their 20s and over 35% of women aged 30 to 39 years struggle with adult female cystic acne.